Mangoceuticals (MGRX) Change in Cash (2023 - 2026)

Mangoceuticals has disclosed Change in Cash across 4 years of filings, most recently posting $56438.0 for Q2 2026.

• In Q2 2026, Change in Cash rose 131.91% year-over-year to $56438.0; the TTM figure through Jun 2026 stood at $131140.0 (up 133.77% YoY), while the FY2025 annual figure was $1.4 million, up 311.87% from the prior year.
• Change in Cash came in at $56438.0 for Q2 2026 at Mangoceuticals, up from -$1.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $3.2 million in Q1 2023 to a low of -$1.7 million in Q3 2023.
• Average Change in Cash over 4 years is -$32047.6, with a median of $1571.0 recorded in 2024.
• Year-over-year, Change in Cash jumped 14311.36% in 2025 and tumbled 12932.4% in 2026.
• Over 4 years, Change in Cash stood at -$497741.0 in 2023, then jumped by 98.58% to -$7077.0 in 2024, then jumped by 14311.36% to $1.0 million in 2025, then plunged by 94.39% to $56438.0 in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $56438.0 in Q2 2026, -$1.3 million in Q1 2026, and $1.0 million in Q4 2025.